Claudius LLC insider trades: Acura Pharmaceuticals (ACUR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Claudius LLC reports to the SEC
Open-market buys and sales
78 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | ACUR | ↓ Sell | 2,195,734 | $0.10 | $220K | Indirect | Jan 2, 2018 (19d) |
| Jun 17, 2015 | ACUR | ↓ Sell | 104,823 | $1.08 | $114K | See FN | Jun 18, 2015 (1d) |
| Jan 12, 2015 | ACUR | ↓ Sell | 171,000 | $0.62 | $106K | See FN | Jan 12, 2015 (0d) |
| Mar 3, 2014 | ACUR | ↓ Sell | 2,500 | $2.00 | $5K | See FN | Mar 5, 2014 (2d) |
| Feb 28, 2014 | ACUR | ↓ Sell | 351,260 | $2.02 | $711K | See FN | Feb 28, 2014 (0d) |
| Feb 24, 2014 | ACUR | ↓ Sell | 44,019 | $1.97 | $87K | See FN | Feb 25, 2014 (1d) |
| Feb 18, 2014 | ACUR | ↓ Sell | 2,200 | $1.95 | $4K | See FN | Feb 20, 2014 (2d) |
| Oct 10, 2013 | ACUR | ↓ Sell | 4,200 | $2.05 | $9K | See FN | Oct 11, 2013 (1d) |
| Jul 2, 2013 | ACUR | ↓ Sell | 200,000 | $2.15 | $430K | See FN | Jul 3, 2013 (1d) |
| Jun 17, 2013 | ACUR | ↓ Sell | 20,446 | $2.15 | $44K | See FN | Jun 19, 2013 (2d) |
| Jun 14, 2013 | ACUR | ↓ Sell | 31,283 | $2.16 | $67K | See FN | Jun 14, 2013 (0d) |
| Jun 10, 2013 | ACUR | ↓ Sell | 21,496 | $2.20 | $47K | See FN | Jun 11, 2013 (1d) |
| Jun 6, 2013 | ACUR | ↓ Sell | 39,453 | $2.19 | $86K | See FN | Jun 7, 2013 (1d) |
| May 31, 2013 | ACUR | ↓ Sell | 31,559 | $2.25 | $71K | See FN | Jun 3, 2013 (3d) |
| May 21, 2013 | ACUR | ↓ Sell | 47,410 | $2.30 | $109K | See FN | May 23, 2013 (2d) |
| May 20, 2013 | ACUR | ↓ Sell | 166,052 | $2.33 | $388K | See FN | May 20, 2013 (0d) |
| May 15, 2013 | ACUR | ↓ Sell | 183,434 | $2.33 | $427K | See FN | May 15, 2013 (0d) |
| May 7, 2013 | ACUR | ↓ Sell | 153,304 | $2.16 | $331K | See FN | May 7, 2013 (0d) |
| May 2, 2013 | ACUR | ↓ Sell | 174,758 | $2.41 | $422K | See FN | May 2, 2013 (0d) |
| Apr 29, 2013 | ACUR | ↓ Sell | 56,342 | $2.59 | $146K | See FN | Apr 29, 2013 (0d) |
| Apr 17, 2013 | ACUR | ↓ Sell | 238,756 | $3.20 | $765K | See FN | Apr 19, 2013 (2d) |
| Apr 16, 2013 | ACUR | ↓ Sell | 39,303 | $2.14 | $84K | See FN | Apr 16, 2013 (0d) |
| Apr 11, 2013 | ACUR | ↓ Sell | 121,454 | $2.23 | $270K | See FN | Apr 11, 2013 (0d) |
| Apr 9, 2013 | ACUR | ↓ Sell | 200,487 | $2.16 | $432K | See FN | Apr 9, 2013 (0d) |
| May 18, 2010 | MDAS | ↓ Sell | 30,856 | $24.11 | $744K | See FN | May 19, 2010 (1d) |
| Apr 26, 2010 | MDAS | ↓ Sell | 111,708 | $22.24 | $2.5M | See FN | Apr 26, 2010 (0d) |
| Mar 23, 2010 | MDAS | ↓ Sell | 42,373 | $22.13 | $938K | See FN | Mar 23, 2010 (0d) |
| Mar 18, 2010 | MDAS | ↓ Sell | 8,818 | $22.06 | $195K | See FN | Mar 18, 2010 (0d) |
| Nov 2, 2009 | MDAS | ↓ Sell | 55,584 | $22.11 | $1.2M | Indirect | Nov 3, 2009 (1d) |
| Oct 8, 2009 | MDAS | ↓ Sell | 15,199 | $22.06 | $335K | Indirect | Oct 13, 2009 (5d) |
| Oct 6, 2009 | MDAS | ↓ Sell | 10,047 | $22.06 | $222K | Indirect | Oct 7, 2009 (1d) |
| Oct 2, 2009 | MDAS | ↓ Sell | 30,608 | $22.12 | $677K | Indirect | Oct 5, 2009 (3d) |
| Sep 15, 2009 | MDAS | ↓ Sell | 55,854 | $22.19 | $1.2M | Indirect | Sep 17, 2009 (2d) |
| Aug 3, 2009 | MDAS | ↓ Sell | 41,346 | $19.00 | $786K | By Galen Partners III, L.P. | Aug 5, 2009 (2d) |
| Aug 3, 2009 | MDAS | ↓ Sell | 9,824 | $19.00 | $187K | By Galen Partners IV, L.P. | Aug 5, 2009 (2d) |
| Aug 3, 2009 | MDAS | ↓ Sell | 3,747 | $19.00 | $71K | By Galen Partners International III, L.P | Aug 5, 2009 (2d) |
| Aug 3, 2009 | MDAS | ↓ Sell | 780 | $19.00 | $15K | By Galen Partners International IV, L.P. | Aug 5, 2009 (2d) |
| Aug 3, 2009 | MDAS | ↓ Sell | 142 | $19.00 | $3K | By Galen Employee Fund III, L.P. | Aug 5, 2009 (2d) |
| Aug 3, 2009 | MDAS | ↓ Sell | 11 | $19.00 | $209 | By Galen Employee Fund IV, L.P. | Aug 5, 2009 (2d) |
| Jul 1, 2009 | MDAS | ↓ Sell | 41,346 | $19.16 | $792K | By Galen Partners III, L.P. | Jul 2, 2009 (1d) |
| Jul 1, 2009 | MDAS | ↓ Sell | 9,825 | $19.16 | $188K | By Galen Partners IV, L.P. | Jul 2, 2009 (1d) |
| Jul 1, 2009 | MDAS | ↓ Sell | 3,747 | $19.16 | $72K | By Galen Partners International III, L.P | Jul 2, 2009 (1d) |
| Jul 1, 2009 | MDAS | ↓ Sell | 780 | $19.16 | $15K | By Galen Partners International IV, L.P. | Jul 2, 2009 (1d) |
| Jul 1, 2009 | MDAS | ↓ Sell | 142 | $19.16 | $3K | By Galen Employee Fund III, L.P. | Jul 2, 2009 (1d) |
| Jul 1, 2009 | MDAS | ↓ Sell | 14 | $19.16 | $268 | By Galen Employee Fund IV, L.P. | Jul 2, 2009 (1d) |
| Jun 10, 2009 | MDAS | ↓ Sell | 41,346 | $17.06 | $705K | By Galen Partners III, L.P. | Jun 17, 2009 (7d) |
| Jun 10, 2009 | MDAS | ↓ Sell | 9,825 | $17.06 | $168K | By Galen Partners IV, L.P. | Jun 17, 2009 (7d) |
| Jun 10, 2009 | MDAS | ↓ Sell | 3,747 | $17.06 | $64K | By Galen Partners International III, L.P | Jun 17, 2009 (7d) |
| Jun 10, 2009 | MDAS | ↓ Sell | 780 | $17.06 | $13K | By Galen Partners International IV, L.P. | Jun 17, 2009 (7d) |
| Jun 10, 2009 | MDAS | ↓ Sell | 142 | $17.06 | $2K | By Galen Employee Fund III, L.P. | Jun 17, 2009 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Claudius LLC's insider trades
Claudius LLC is an insider at Acura Pharmaceuticals (ACUR). Since Jun 6, 2008, it has reported no open-market purchases and 78 sales worth $40.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACUR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.